IART
Integra LifeSciences Holdings Corporation · Healthcare · Medical - Devices
Momentum inputs (comparable managers): holder breadth 0.0% · share flow -29.2% · net new positions 0.0% — formula
All ownership figures: tracked 13F managers only, common-stock positions, reporting period Q3 2024
| Quarter | Holders | Δ | Shares | Reported value | New | Exits |
|---|---|---|---|---|---|---|
| Q2 2026 | 83 | +6 | 47.61M | $854.64M | +10 | −4 |
| Q1 2026 | 80 | -2 | 47.10M | $443.79M | +5 | −7 |
| Q4 2025 | 82 | +1 | 50.51M | $627.34M | +2 | −1 |
| Q3 2025 | 15 | -2 | 31.34M | $449.05M | — | −2 |
| Q2 2025 | 14 | +1 | 26.22M | $321.73M | +1 | — |
| Q1 2025 | 10 | -2 | 8.70M | $191.38M | — | −2 |
| Q4 2024 | 12 | -1 | 8.85M | $200.63M | — | −1 |
| Q3 2024 | 12 | 0 | 6.56M | $119.23M | +1 | −1 |
| Q2 2024 | 12 | — | 9.27M | $269.75M | — | — |
| # | Manager | Shares | Δ shares | Value | Their weight | Held | ||
|---|---|---|---|---|---|---|---|---|
| 1 | Wellington Management ✦ | 2.20M | -43.3% | $40.02M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 2 | Wellington Management ✦ | 2.20M | -43.3% | $40.02M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 3 | Wellington Management ✦ | 2.20M | -43.3% | $40.02M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 4 | Wellington Management ✦ | 2.20M | -43.3% | $40.02M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 5 | Wellington Management ✦ | 2.20M | -43.3% | $40.02M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 6 | Wellington Management ✦ | 2.20M | -43.3% | $40.02M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 7 | Wellington Management ✦ | 2.20M | -43.3% | $40.02M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 8 | Wellington Management ✦ | 2.20M | -43.3% | $40.02M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 9 | Geode Capital Management ✦ (passive) | 1.82M | -0.2% | $33.15M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 10 | Geode Capital Management ✦ (passive) | 1.82M | -0.2% | $33.15M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 11 | D. E. Shaw & Co. ✦ | 1.02M | +19.6% | $18.59M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 12 | D. E. Shaw & Co. ✦ | 1.02M | +19.6% | $18.59M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 13 | Two Sigma Investments ✦ | 671.45K | +51.4% | $12.20M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 14 | Fisher Asset Management ✦ | 399.72K | 0.0% | $7.26M | 0.0% | Held | 2 | SEC ↗ |
| 15 | Millennium Management ✦ | 191.80K | +995.0% | $3.49M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 16 | Millennium Management ✦ | 191.80K | +995.0% | $3.49M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 17 | AQR Capital Management ✦ | 87.75K | -85.7% | $1.57M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 18 | AQR Capital Management ✦ | 87.75K | -85.7% | $1.57M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 19 | Norges Bank ✦ (passive) | 45.32K | -93.4% | $823,501 | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 20 | T. Rowe Price ✦ | 42.64K | +1.5% | $775,000 | 0.0% | ▲ Add | 2 | SEC ↗ |
| 21 | Citadel Advisors ✦ | 32.41K | -87.1% | $588,926 | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 22 | Citadel Advisors ✦ | 32.41K | -87.1% | $588,926 | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 23 | Bridgewater Associates ✦ | 29.53K | -73.9% | $536,615 | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 24 | Arrowstreet Capital ✦ | 12.84K | New | $233,357 | 0.0% | New | 1 | SEC ↗ |
“Their weight” = the position's share of that manager's reported 13F equity value — the conviction measure. ✦ = curated manager.
New buyers
| Arrowstreet Capital | $233,357 | 0.0% |
Exited
| Gotham Asset Management | $3.94M | was 0.1% |
Full-market context: across ALL 13F filers (SEC structured data, Q1 2026): 200 holders, 74.41M shares, $694.31M reported. This is a different, older period than the tracked-universe figures above and the two are never mixed.
What else this security's tracked holders most often hold — shared-ownership counts, not fundamental relationships.